Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
This report aims to provide a comprehensive presentation of the global market for Long Acting Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long Acting Drug Delivery. This report contains market size and forecasts of Long Acting Drug Delivery in global, including the following market information:
Global Long Acting Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Long Acting Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Device Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Long Acting Drug Delivery include ViiV Healthcare, Halozyme Therapeutics, Lubrizol Life Science, Celanese Corporation, Kashiv BioSciences, 4P Therapeutics, Ipsen, Midatech Pharma and Re-Vana Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Long Acting Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long Acting Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Long Acting Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Device
Parenteral Injections
Global Long Acting Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Long Acting Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospital
Specialty Clinics
Clinical Research Institutes
Others
Global Long Acting Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Long Acting Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Long Acting Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Long Acting Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Long Acting Drug Delivery, market overview.
Chapter 2: Global Long Acting Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Long Acting Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Long Acting Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Long Acting Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Long Acting Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Long Acting Drug Delivery Overall Market Size
2.1 Global Long Acting Drug Delivery Market Size: 2022 VS 2032
2.2 Global Long Acting Drug Delivery Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Long Acting Drug Delivery Players in Global Market
3.2 Top Global Long Acting Drug Delivery Companies Ranked by Revenue
3.3 Global Long Acting Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Long Acting Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Long Acting Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Long Acting Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Long Acting Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Long Acting Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Long Acting Drug Delivery Market Size Markets, 2022 & 2032
4.1.2 Device
4.1.3 Parenteral Injections
4.2 By Type - Global Long Acting Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Long Acting Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Long Acting Drug Delivery Revenue, 2024-2032
4.2.3 By Type - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Long Acting Drug Delivery Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Specialty Clinics
5.1.4 Clinical Research Institutes
5.1.5 Others
5.2 By Application - Global Long Acting Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Long Acting Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Long Acting Drug Delivery Revenue, 2024-2032
5.2.3 By Application - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Long Acting Drug Delivery Market Size, 2022 & 2032
6.2 By Region - Global Long Acting Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Long Acting Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Long Acting Drug Delivery Revenue, 2024-2032
6.2.3 By Region - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Long Acting Drug Delivery Revenue, 2018-2032
6.3.2 US Long Acting Drug Delivery Market Size, 2018-2032
6.3.3 Canada Long Acting Drug Delivery Market Size, 2018-2032
6.3.4 Mexico Long Acting Drug Delivery Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Long Acting Drug Delivery Revenue, 2018-2032
6.4.2 Germany Long Acting Drug Delivery Market Size, 2018-2032
6.4.3 France Long Acting Drug Delivery Market Size, 2018-2032
6.4.4 U.K. Long Acting Drug Delivery Market Size, 2018-2032
6.4.5 Italy Long Acting Drug Delivery Market Size, 2018-2032
6.4.6 Russia Long Acting Drug Delivery Market Size, 2018-2032
6.4.7 Nordic Countries Long Acting Drug Delivery Market Size, 2018-2032
6.4.8 Benelux Long Acting Drug Delivery Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Long Acting Drug Delivery Revenue, 2018-2032
6.5.2 China Long Acting Drug Delivery Market Size, 2018-2032
6.5.3 Japan Long Acting Drug Delivery Market Size, 2018-2032
6.5.4 South Korea Long Acting Drug Delivery Market Size, 2018-2032
6.5.5 Southeast Asia Long Acting Drug Delivery Market Size, 2018-2032
6.5.6 India Long Acting Drug Delivery Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Long Acting Drug Delivery Revenue, 2018-2032
6.6.2 Brazil Long Acting Drug Delivery Market Size, 2018-2032
6.6.3 Argentina Long Acting Drug Delivery Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Long Acting Drug Delivery Revenue, 2018-2032
6.7.2 Turkey Long Acting Drug Delivery Market Size, 2018-2032
6.7.3 Israel Long Acting Drug Delivery Market Size, 2018-2032
6.7.4 Saudi Arabia Long Acting Drug Delivery Market Size, 2018-2032
6.7.5 UAE Long Acting Drug Delivery Market Size, 2018-2032
7 Long Acting Drug Delivery Companies Profiles
7.1 ViiV Healthcare
7.1.1 ViiV Healthcare Company Summary
7.1.2 ViiV Healthcare Business Overview
7.1.3 ViiV Healthcare Long Acting Drug Delivery Major Product Offerings
7.1.4 ViiV Healthcare Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 ViiV Healthcare Key News & Latest Developments
7.2 Halozyme Therapeutics
7.2.1 Halozyme Therapeutics Company Summary
7.2.2 Halozyme Therapeutics Business Overview
7.2.3 Halozyme Therapeutics Long Acting Drug Delivery Major Product Offerings
7.2.4 Halozyme Therapeutics Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Halozyme Therapeutics Key News & Latest Developments
7.3 Lubrizol Life Science
7.3.1 Lubrizol Life Science Company Summary
7.3.2 Lubrizol Life Science Business Overview
7.3.3 Lubrizol Life Science Long Acting Drug Delivery Major Product Offerings
7.3.4 Lubrizol Life Science Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Lubrizol Life Science Key News & Latest Developments
7.4 Celanese Corporation
7.4.1 Celanese Corporation Company Summary
7.4.2 Celanese Corporation Business Overview
7.4.3 Celanese Corporation Long Acting Drug Delivery Major Product Offerings
7.4.4 Celanese Corporation Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Celanese Corporation Key News & Latest Developments
7.5 Kashiv BioSciences
7.5.1 Kashiv BioSciences Company Summary
7.5.2 Kashiv BioSciences Business Overview
7.5.3 Kashiv BioSciences Long Acting Drug Delivery Major Product Offerings
7.5.4 Kashiv BioSciences Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Kashiv BioSciences Key News & Latest Developments
7.6 4P Therapeutics
7.6.1 4P Therapeutics Company Summary
7.6.2 4P Therapeutics Business Overview
7.6.3 4P Therapeutics Long Acting Drug Delivery Major Product Offerings
7.6.4 4P Therapeutics Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 4P Therapeutics Key News & Latest Developments
7.7 Ipsen
7.7.1 Ipsen Company Summary
7.7.2 Ipsen Business Overview
7.7.3 Ipsen Long Acting Drug Delivery Major Product Offerings
7.7.4 Ipsen Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Ipsen Key News & Latest Developments
7.8 Midatech Pharma
7.8.1 Midatech Pharma Company Summary
7.8.2 Midatech Pharma Business Overview
7.8.3 Midatech Pharma Long Acting Drug Delivery Major Product Offerings
7.8.4 Midatech Pharma Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Midatech Pharma Key News & Latest Developments
7.9 Re-Vana Therapeutics
7.9.1 Re-Vana Therapeutics Company Summary
7.9.2 Re-Vana Therapeutics Business Overview
7.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Major Product Offerings
7.9.4 Re-Vana Therapeutics Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 Re-Vana Therapeutics Key News & Latest Developments
7.10 Creative Biolabs
7.10.1 Creative Biolabs Company Summary
7.10.2 Creative Biolabs Business Overview
7.10.3 Creative Biolabs Long Acting Drug Delivery Major Product Offerings
7.10.4 Creative Biolabs Long Acting Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Creative Biolabs Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Long Acting Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Long Acting Drug Delivery Market Drivers in Global Market
Table 3. Long Acting Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Long Acting Drug Delivery in Global Market
Table 5. Top Long Acting Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Long Acting Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Long Acting Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Long Acting Drug Delivery Product Type
Table 9. List of Global Tier 1 Long Acting Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long Acting Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Long Acting Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Long Acting Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Long Acting Drug Delivery Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Long Acting Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Long Acting Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Long Acting Drug Delivery Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Long Acting Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Long Acting Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Long Acting Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Long Acting Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Long Acting Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 30. ViiV Healthcare Company Summary
Table 31. ViiV Healthcare Long Acting Drug Delivery Product Offerings
Table 32. ViiV Healthcare Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. ViiV Healthcare Key News & Latest Developments
Table 34. Halozyme Therapeutics Company Summary
Table 35. Halozyme Therapeutics Long Acting Drug Delivery Product Offerings
Table 36. Halozyme Therapeutics Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Halozyme Therapeutics Key News & Latest Developments
Table 38. Lubrizol Life Science Company Summary
Table 39. Lubrizol Life Science Long Acting Drug Delivery Product Offerings
Table 40. Lubrizol Life Science Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Lubrizol Life Science Key News & Latest Developments
Table 42. Celanese Corporation Company Summary
Table 43. Celanese Corporation Long Acting Drug Delivery Product Offerings
Table 44. Celanese Corporation Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Celanese Corporation Key News & Latest Developments
Table 46. Kashiv BioSciences Company Summary
Table 47. Kashiv BioSciences Long Acting Drug Delivery Product Offerings
Table 48. Kashiv BioSciences Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Kashiv BioSciences Key News & Latest Developments
Table 50. 4P Therapeutics Company Summary
Table 51. 4P Therapeutics Long Acting Drug Delivery Product Offerings
Table 52. 4P Therapeutics Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. 4P Therapeutics Key News & Latest Developments
Table 54. Ipsen Company Summary
Table 55. Ipsen Long Acting Drug Delivery Product Offerings
Table 56. Ipsen Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Ipsen Key News & Latest Developments
Table 58. Midatech Pharma Company Summary
Table 59. Midatech Pharma Long Acting Drug Delivery Product Offerings
Table 60. Midatech Pharma Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Midatech Pharma Key News & Latest Developments
Table 62. Re-Vana Therapeutics Company Summary
Table 63. Re-Vana Therapeutics Long Acting Drug Delivery Product Offerings
Table 64. Re-Vana Therapeutics Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. Re-Vana Therapeutics Key News & Latest Developments
Table 66. Creative Biolabs Company Summary
Table 67. Creative Biolabs Long Acting Drug Delivery Product Offerings
Table 68. Creative Biolabs Long Acting Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. Creative Biolabs Key News & Latest Developments
List of Figures
Figure 1. Long Acting Drug Delivery Segment by Type in 2022
Figure 2. Long Acting Drug Delivery Segment by Application in 2022
Figure 3. Global Long Acting Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Long Acting Drug Delivery Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Long Acting Drug Delivery Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Long Acting Drug Delivery Revenue in 2022
Figure 8. By Type - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 9. By Application - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 10. By Type - Global Long Acting Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 12. By Application - Global Long Acting Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 14. By Region - Global Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 15. By Country - North America Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 16. US Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 20. Germany Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 21. France Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 28. China Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 32. India Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 34. Brazil Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Long Acting Drug Delivery Revenue Market Share, 2018-2032
Figure 37. Turkey Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Long Acting Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 41. ViiV Healthcare Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Halozyme Therapeutics Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Lubrizol Life Science Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Celanese Corporation Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Kashiv BioSciences Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. 4P Therapeutics Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ipsen Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Midatech Pharma Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Re-Vana Therapeutics Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Creative Biolabs Long Acting Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
